Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

The genetic mapping and gene structure of mouse paraoxonase/arylesterase.

Sorenson RC, Primo-Parmo SL, Camper SA, La Du BN.

Genomics. 1995 Dec 10;30(3):431-8.

PMID:
8825627
2.

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN.

Genomics. 1996 May 1;33(3):498-507.

PMID:
8661009
3.
4.

Serum paraoxonase and arylesterase activities in hemodialysis patients.

Itahara T, Suehiro T, Ikeda Y, Inoue M, Nakamura T, Kumon Y, Kawada M, Hashimoto K.

J Atheroscler Thromb. 2000;7(3):152-8.

PMID:
11480456
5.

Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression.

Li WF, Matthews C, Disteche CM, Costa LG, Furlong CE.

Pharmacogenetics. 1997 Apr;7(2):137-44.

PMID:
9170151
6.

Gene therapy to prevent organophosphate intoxication.

Cowan J, Sinton CM, Varley AW, Wians FH, Haley RW, Munford RS.

Toxicol Appl Pharmacol. 2001 May 15;173(1):1-6.

PMID:
11350209
7.

Structural organization of the human PON1 gene.

Clendenning JB, Humbert R, Green ED, Wood C, Traver D, Furlong CE.

Genomics. 1996 Aug 1;35(3):586-9.

PMID:
8812495
8.

Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.

Wills AM, Landers JE, Zhang H, Richter RJ, Caraganis AJ, Cudkowicz ME, Furlong CE, Brown RH Jr.

Neurology. 2008 Mar 18;70(12):929-34. doi: 10.1212/01.wnl.0000305956.37931.dd.

PMID:
18347314
9.
10.

Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.

Bryk B, BenMoyal-Segal L, Podoly E, Livnah O, Eisenkraft A, Luria S, Cohen A, Yehezkelli Y, Hourvitz A, Soreq H.

J Neurochem. 2005 Mar;92(5):1216-27.

11.

Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.

Can Demirdöğen B, Türkanoğlu A, Bek S, Sanisoğlu Y, Demirkaya S, Vural O, Arinç E, Adali O.

Clin Biochem. 2008 Jan;41(1-2):1-9. Epub 2007 Aug 24.

PMID:
17920578
12.
13.

Rabbits possess a serum paraoxonase polymorphism similar to the human Q192R.

Watson CE, Draganov DI, Billecke SS, Bisgaier CL, La Du BN.

Pharmacogenetics. 2001 Mar;11(2):123-34.

PMID:
11266077
14.

Serum paraoxonase (PON1) concentration in patients undergoing hemodialysis.

Suehiro T, Ikeda Y, Shiinoki T, Inoue M, Kumon Y, Itahara T, Hashimoto K.

J Atheroscler Thromb. 2002;9(3):133-8.

15.

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice.

Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW, Lusis AJ, Shih DM.

Circulation. 2002 Jul 23;106(4):484-90.

16.

Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.

Furlong CE, Li WF, Costa LG, Richter RJ, Shih DM, Lusis AJ.

Neurotoxicology. 1998 Aug-Oct;19(4-5):645-50.

PMID:
9745924
17.

Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activity.

Connelly PW, Maguire GF, Draganov DI.

J Lipid Res. 2004 Mar;45(3):561-6. Epub 2004 Jan 1.

18.

Human serum paraoxonase (PON1) activity in acute organophosphorous insecticide poisoning.

Akgür SA, Oztürk P, Solak I, Moral AR, Ege B.

Forensic Sci Int. 2003 Apr 23;133(1-2):136-40.

PMID:
12742701
19.

Structure and chromosomal localization of the mouse SNAP-23 gene.

Vaidyanathan VV, Roche PA.

Gene. 2000 Apr 18;247(1-2):181-9.

PMID:
10773458
20.

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.

Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ.

Nature. 1998 Jul 16;394(6690):284-7.

PMID:
9685159

Supplemental Content

Support Center